The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution

Phase 3, randomized, placebo-controlled trial of orteronel (TAK-700) plus prednisone in patients (pts) with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) (ELM-PC 4 trial)

Ronald De Wit

Consultant or Advisory Role - Millennium

Honoraria - Millennium

Karim Fizazi

Consultant or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Ipsen; Janssen; Medivation; Millennium; Novartis; Sanofi

Viorel Jinga

Honoraria - Astellas Pharma; Janssen; Takeda

Eleni Efstathiou

Consultant or Advisory Role - Bayer; Janssen; Medivation; Millennium; Sanofi

Honoraria - Janssen; Millennium; Sanofi

Research Funding - Janssen; Millennium; Sanofi ; Viamet Pharmaceuticals

Peter C.C. Fong

Consultant or Advisory Role - Janssen-Cilag

Manfred Wirth

Consultant or Advisory Role - Bayer; Dendreon; Farco-Pharma; Ferring; Janssen; Merck; Orion Corporation ; Teva

Honoraria - Apogepha; Janssen; Orion Corporation ; Pfizer

Research Funding - Takeda

Kazuhiro Suzuki

Consultant or Advisory Role - Millennium; Takeda

Honoraria - Astellas Pharma; Sanofi ; Takeda

Research Funding - Astellas Pharma; Sanofi ; Takeda

Susan Moran

Employment or Leadership Position - Takeda

Ling Wang

Employment or Leadership Position - Takeda

Hideyuki Akaza

Consultant or Advisory Role - Takeda

Honoraria - Astellas Pharma; Otsuka; Takeda

Research Funding - Takeda; University of Tokyo

Joel Nelson

Consultant or Advisory Role - Millennium

Howard I. Scher

Consultant or Advisory Role - Millennium

Robert Dreicer

Consultant or Advisory Role - Dendreon; Endo Pharmaceuticals; Janssen; Medivation; Millennium

Honoraria - Dendreon; Janssen

Research Funding - BIND Biosciences; Dendreon; Millennium; Progenics

Niels Geert Borgstein

Employment or Leadership Position - Takeda

Stock Ownership - Takeda

Fred Saad

Consultant or Advisory Role - Astellas Pharma; Janssen; Millennium

Honoraria - Astellas Pharma; Janssen

Research Funding - Astellas Pharma; Janssen; Millennium